Advances in the treatment of non-Hodgkin's lymphoma

被引:9
|
作者
Cerny, T [1 ]
Gillessen, S [1 ]
机构
[1] Kantonsspital St Gallen, Dept Internal Med, Div Hematol & Oncol, St Gallen, Switzerland
关键词
D O I
10.1093/annonc/mdf662
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:211 / 216
页数:6
相关论文
共 50 条
  • [1] Advances in treatment for non-Hodgkin"s lymphoma
    Gerrard, MP
    [J]. CANCER AND THE ADOLESCENT, SECOND EDITION, 2005, : 72 - 82
  • [2] Immunotherapy in non-Hodgkin's lymphoma: Treatment advances
    Fisher, RI
    [J]. SEMINARS IN ONCOLOGY, 2003, 30 (02) : 1 - 2
  • [3] Recent Advances in Nanobiotechnology for the Treatment of Non-Hodgkin's Lymphoma
    Liu, Shuxian
    Xu, Minghao
    Zhong, Lei
    Tong, Xiangmin
    Qian, Suying
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2024, 24 (09) : 895 - 907
  • [4] Treatment of non-Hodgkin's lymphoma
    Dranitsaris, G
    [J]. ANTI-CANCER DRUGS, 1998, 9 (10) : 879 - 888
  • [5] Current therapeutic advances in the treatment of non-Hodgkin lymphoma
    Hernandez-Rivera, Gabriela
    Aguayo-Gonzalez, Alvaro
    Cano-Castellanos, Raul
    Martin Loarca-Pina, Luis
    [J]. GACETA MEDICA DE MEXICO, 2008, 144 (03): : 275 - 277
  • [6] Childhood non-Hodgkin's lymphoma: Recent advances
    Patte, C
    [J]. EJC SUPPLEMENTS, 2003, 1 (06): : 15 - 21
  • [7] The treatment of Hodgkin's and non-Hodgkin's lymphoma in pregnancy
    Pereg, David
    Koren, Gideon
    Lishner, Michael
    [J]. HAEMATOLOGICA, 2007, 92 (09) : 1230 - 1237
  • [8] Romidepsin for the treatment of non-Hodgkin's lymphoma
    Yazbeck, Victor Y.
    Grant, Steven
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2015, 24 (07) : 965 - 979
  • [9] Bortezomib for the treatment of non-Hodgkin's lymphoma
    Bose, Prithviraj
    Batalo, Michael S.
    Holkova, Beata
    Grant, Steven
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (16) : 2443 - 2459
  • [10] A revolution in the treatment of non-Hodgkin's lymphoma
    DeNardo, GL
    O'Donnell, RT
    Oldham, RK
    DeNardo, SJ
    [J]. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 1998, 13 (04) : 213 - 223